Rochester, NY 7/11/2009 3:24:05 AM
WhisperfromWallStreet.com Stock Report - XNPT - XenoPort Announces Pricing of Public Offering of Common Stock
Xenoport, Inc.
WhisperfromWallStreet.com Stock Report - XNPT - XenoPort Announces Pricing of Public Offering of Common Stock
---
Xenoport, Inc.,XNPT
Last Trade: 19.06
Day's Range: 18.95 - 19.26
52wk Range: 13.36 - 51.42
Volume: 117,671
XenoPort, Inc. announced today the pricing of an underwritten public offering of 2,500,000 shares of its common stock at a price to the public of $19.00 per share. XenoPort has granted the underwriters a 30-day option to purchase up to an additional 375,000 shares of common stock to cover over-allotments, if any.
19.11 Down 0.06 (0.31%) 4:06pm ET
ABOUT THE COMPANY
XenoPort, Inc., a biopharmaceutical company, focuses on developing internally discovered product candidates that utilize the body's natural nutrient transport mechanisms to enhance the therapeutic benefits of drugs. Its portfolio of product candidates includes XP13512, which is a transported prodrug of gabapentin, has been evaluated in a phase III clinical program for the treatment of restless legs syndrome, as well as completed a phase IIa clinical trial for the management of post-herpetic neuralgia.
---
There are hundreds of stocks that rise and fall each day, our expertise is understanding which have the best opportunity for rapid growth. Our newsletter has sent out over 40 alerts this year with an average price gain of 80%. If you like to be alerted to the stocks that meets our criteria. Please join us for free to track our results.
You can sign up now for free stock alerts at WhisperfromWallStreet.com
---
Please read the COMPLETE DISCLAIMER posted on our website.
IMPORTANT NOTE: This is not a solicitation to buy or sell any securities. Neither WhisperfromWallStreet.com, nor any of its affiliates are registered investment advisors or a broker dealer. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.
